tetano
Editor, Senior Moderator
STAR Protoc
. 2022 Apr 22;3(2):101387.
doi: 10.1016/j.xpro.2022.101387. eCollection 2022 Jun 17.
Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape
Naveenchandra Suryadevara[SUP] 1 [/SUP], Pavlo Gilchuk[SUP] 1 [/SUP], Seth J Zost[SUP] 1 [/SUP], Nikhil Mittal[SUP] 2 [/SUP], Li Leyna Zhao[SUP] 2 [/SUP], James E Crowe Jr[SUP] 1 3 4 [/SUP], Robert H Carnahan[SUP] 1 4 [/SUP]
Affiliations
Abstract
Real-time cell analysis (RTCA) enables high-throughput, quantitative kinetic measurements of cytopathic effect (CPE) in virus-infected cells. Here, we detail a RTCA approach for assessing antibody neutralization. We describe how to evaluate the neutralizing potency of monoclonal antibodies (mAbs) and identify viral escape mutants to antibody neutralization for severe respiratory syndrome coronavirus 2 (SARS-CoV-2). For complete details on the use and execution of this protocol, please refer to Zost et al. (2020) and Suryadevara et al. (2021).
Keywords: Antibody; Biotechnology and bioengineering; Cell-based Assays; Health Sciences; High Throughput Screening; Immunology; Microbiology.
. 2022 Apr 22;3(2):101387.
doi: 10.1016/j.xpro.2022.101387. eCollection 2022 Jun 17.
Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape
Naveenchandra Suryadevara[SUP] 1 [/SUP], Pavlo Gilchuk[SUP] 1 [/SUP], Seth J Zost[SUP] 1 [/SUP], Nikhil Mittal[SUP] 2 [/SUP], Li Leyna Zhao[SUP] 2 [/SUP], James E Crowe Jr[SUP] 1 3 4 [/SUP], Robert H Carnahan[SUP] 1 4 [/SUP]
Affiliations
- PMID: 35578733
- PMCID: PMC9023333
- DOI: 10.1016/j.xpro.2022.101387
Abstract
Real-time cell analysis (RTCA) enables high-throughput, quantitative kinetic measurements of cytopathic effect (CPE) in virus-infected cells. Here, we detail a RTCA approach for assessing antibody neutralization. We describe how to evaluate the neutralizing potency of monoclonal antibodies (mAbs) and identify viral escape mutants to antibody neutralization for severe respiratory syndrome coronavirus 2 (SARS-CoV-2). For complete details on the use and execution of this protocol, please refer to Zost et al. (2020) and Suryadevara et al. (2021).
Keywords: Antibody; Biotechnology and bioengineering; Cell-based Assays; Health Sciences; High Throughput Screening; Immunology; Microbiology.